(Q54541037)
Statements
Preferential binding of the anticancer drug rViscumin (recombinant mistletoe lectin) to terminally alpha2-6-sialylated neolacto-series gangliosides. (English)
1 reference
Johannes Müthing
1 reference
Monika Burg
1 reference
Babette Möckel
1 reference
Martin Langer
1 reference
Wolfgang Metelmann-Strupat
1 reference
Andreas Werner
1 reference
Ulrich Neumann
1 reference
Jasna Peter-Katalinic
1 reference
Jürgen Eck
1 reference
1 August 2002
1 reference
1 reference
12
1 reference
8
1 reference
485-497
1 reference
Identifiers
1 reference